Lipidized deferoxamine nanomedicines (DFOsomes) against iron overload.
Saved in:
| Title: | Lipidized deferoxamine nanomedicines (DFOsomes) against iron overload. |
|---|---|
| Authors: | Li Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Duan J; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Ji J; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Zhu F; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; Department of Macromolecular Science, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200437, China., Tan E; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Wang Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Zhai Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China., Wang X; National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China. Electronic address: wangxinyu@jsinm.org., Cheng Y; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; Fengxian Hospital Affiliated to Southern Medical University, Shanghai 201499, China. Electronic address: yycheng@mail.ustc.edu.cn. |
| Source: | Journal of controlled release : official journal of the Controlled Release Society [J Control Release] 2026 Jul 10; Vol. 395, pp. 114939. Date of Electronic Publication: 2026 Apr 18. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 8607908 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-4995 (Electronic) Linking ISSN: 01683659 NLM ISO Abbreviation: J Control Release Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42009223 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lipidized deferoxamine nanomedicines (DFOsomes) against iron overload. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Duan+J%22">Duan J</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Ji+J%22">Ji J</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Zhu+F%22">Zhu F</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; Department of Macromolecular Science, State Key Laboratory of Molecular Engineering of Polymers, Fudan University, Shanghai 200437, China.<br /><searchLink fieldCode="AU" term="%22Tan+E%22">Tan E</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Wang+Y%22">Wang Y</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Zhai+Y%22">Zhai Y</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.<br /><searchLink fieldCode="AU" term="%22Wang+X%22">Wang X</searchLink>; National Health Commission Key Laboratory of Nuclear Medicine, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi 214063, China. Electronic address: wangxinyu@jsinm.org.<br /><searchLink fieldCode="AU" term="%22Cheng+Y%22">Cheng Y</searchLink>; Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China; Fengxian Hospital Affiliated to Southern Medical University, Shanghai 201499, China. Electronic address: yycheng@mail.ustc.edu.cn. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228607908%22">Journal of controlled release : official journal of the Controlled Release Society</searchLink> [J Control Release] 2026 Jul 10; Vol. 395, pp. 114939. <i>Date of Electronic Publication: </i>2026 Apr 18. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Publishers%22">Elsevier Science Publishers </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>8607908 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-4995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201683659%22">01683659 </searchLink><i>NLM ISO Abbreviation: </i>J Control Release <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42009223 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.jconrel.2026.114939 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 114939 Titles: – TitleFull: Lipidized deferoxamine nanomedicines (DFOsomes) against iron overload. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Duan J – PersonEntity: Name: NameFull: Ji J – PersonEntity: Name: NameFull: Zhu F – PersonEntity: Name: NameFull: Tan E – PersonEntity: Name: NameFull: Wang Y – PersonEntity: Name: NameFull: Zhai Y – PersonEntity: Name: NameFull: Wang X – PersonEntity: Name: NameFull: Cheng Y IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 07 Text: 2026 Jul 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1873-4995 Numbering: – Type: volume Value: 395 Titles: – TitleFull: Journal of controlled release : official journal of the Controlled Release Society Type: main |
| ResultId | 1 |